<DOC>
	<DOCNO>NCT01025427</DOCNO>
	<brief_summary>Although highly active antiretroviral therapy ( HAART ) decrease HIV-associated mortality , completely restore health . Patients well otherwise effective HAART remain risk cancer , cardiovascular/liver disease , osteopenia , `` non-AIDS-defining '' event . While complete eradication may never feasible , `` functional cure '' patient able maintain undetectable viral load indefinitely without therapy may possible . The best evidence so-called `` elite '' controller , define individual HIV-seropositive , plasma HIV RNA level level conventional detection without treatment . Controllers may conceptualize naturally occur model functional cure ( `` HIV remission '' ) , ideal patient study HIV persistence possibility eradication . We propose conduct pilot study well characterize reservoir lead viral persistence group well-characterized controller . We propose two specific aim : 1 ) characterize dynamic viral production blood gut-associated lymphoid tissue ( GALT ) controller ; 2 ) prospectively treat 10 controller raltegravir , tenofovir/emtricitabine 24 week study effect HAART viral dynamic host inflammatory response . Our primary hypothesis : 1 ) viral replication ongoing untreated controller , 2 ) HAART reduce viral replication blood GALT decrease immune activation , 3 ) high level immune activation associate great measure microbial translocation distribution virus differentiate T cell subset .</brief_summary>
	<brief_title>HIV Persistence Viral Reservoirs</brief_title>
	<detailed_description />
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Emtricitabine</mesh_term>
	<mesh_term>Raltegravir Potassium</mesh_term>
	<mesh_term>Tenofovir</mesh_term>
	<criteria>1 . Age ≥18 year , 2 . HIV infection , 3 . Antiretroviralnaïve , 4 . CD4+ T cell count &gt; 350 cells/mm3 , 5 . Meeting one follow criterion : 1 . `` Elite controller '' : antiretroviral untreated undetectable ( &lt; 50 copies/mL ) viral load least 12 month ( isolate blip 1,000 copies/mL allow , must precede follow undetectable viral load ) , 2 . `` Noncontrollers '' : antiretroviral untreated detectable ( &gt; 10,000 copies/mL ) viral load , intent start antiretroviral drug . Exclusion criterion : 1 . Persons know rheumatologic condition ( e.g. , systemic lupus erythematosus ) , predilection biologic falsepositive test HIV antibody test . 2 . Screening absolute neutrophil count &lt; 1,000 cells/mm3 , platelet count &lt; 70,000 cells/mm3 , hemoglobin &lt; 8 mg/dL , estimate creatinine clearance &lt; 40 mL/minute , aspartate aminotransferase &gt; 100 units/L , alanine aminotransferase &gt; 100 units/L . 3 . Screening genotype resistance test show resistance tenofovir emtricitabine . 4 . Known kidney disease . 5 . Known bone disease , include pathologic fracture . 6 . Patients chronic Hepatitis B infection , risk liver abnormality start stop tenofovir/emtricitabine . 7 . Concurrent treatment lamivudine , adefovir , entecavir , telbivudine . 8 . Serious illness require hospitalization parental antibiotic within precede 3 month . 9 . Any vaccination 2 week prior baseline ( Day 0 ) visit throughout study period . NOTE : Because study likely actively recruit influenza season , subject encourage receive annual influenza vaccine screen visit ( 4 week prior baseline [ Day 0 ] visit ) already vaccinate 200910 season medically indicate . 10 . Concurrent treatment immunomodulatory drug , exposure immunomodulatory drug precede 16 week ( e.g . corticosteroid therapy equal exceed dose 15 mg/day prednisone 10 day , IL2 , interferonalpha , methotrexate , cancer chemotherapy ) . NOTE : Use inhale nasal steroid use exclusionary . 11 . Concurrent treatment phenobarbital , phenytoin , rifampin . 12 . Pregnant breastfeed woman . Females childbearing potential must negative serum pregnancy test screen agree use doublebarrier method contraception throughout study period .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>April 2012</verification_date>
	<keyword>HIV</keyword>
	<keyword>HIV persistence</keyword>
	<keyword>HIV reservoir</keyword>
</DOC>